TrialThe pharmacogenomics journal2015

Genes involved in pericyte-driven tumor maturation predict treatment benefit of first-line FOLFIRI plus bevacizumab in patients with metastatic colorectal cancer.

N B Volz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.